[go: up one dir, main page]

CN119528857A - A kind of synthetic method of 5-methoxy-3-benzofuranone - Google Patents

A kind of synthetic method of 5-methoxy-3-benzofuranone Download PDF

Info

Publication number
CN119528857A
CN119528857A CN202411429506.4A CN202411429506A CN119528857A CN 119528857 A CN119528857 A CN 119528857A CN 202411429506 A CN202411429506 A CN 202411429506A CN 119528857 A CN119528857 A CN 119528857A
Authority
CN
China
Prior art keywords
methoxy
benzofuranone
compound
synthesizing
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202411429506.4A
Other languages
Chinese (zh)
Inventor
张锐豪
郦荣浩
陈华
倪强
郭小燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Bichen Biochemical Technology Co ltd
Original Assignee
Shanghai Bichen Biochemical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Bichen Biochemical Technology Co ltd filed Critical Shanghai Bichen Biochemical Technology Co ltd
Priority to CN202411429506.4A priority Critical patent/CN119528857A/en
Publication of CN119528857A publication Critical patent/CN119528857A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Furan Compounds (AREA)

Abstract

The invention provides a synthesis method of 5-methoxy-3-benzofuranone, which takes 2-hydroxy-5-methoxy acetophenone as a raw material, firstly converts the 2-hydroxy-5-methoxy acetophenone into an intermediate 2 (2-bromo-1- (2-hydroxy-5-methoxy phenyl) ethanone), and converts the intermediate 2 into a target compound 3 (5-methoxy-3-benzofuranone) under the action of silica gel powder. In the key steps of the synthesis method, alkali is not used, but silica gel powder is used for replacing alkali, so that the post-reaction treatment and purification are simple, the reaction and time cost is greatly reduced, and the process amplification can be realized.

Description

Synthesis method of 5-methoxy-3-benzofuranone
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis method of 5-methoxy-3-benzofuranone.
Background
The compound 5-methoxy-3-benzofuranone is an important molecular building block, 5-methoxy-3-benzofuranone is used as a key intermediate in the synthesis of 3, 4-dihydro-2H-pyrano [3,2-b ] benzofuran-2-one skeleton compounds in patent CN112174974A, the 3, 4-dihydro-2H-pyrano [3,2-b ] benzofuran-2-one skeleton compounds have the application in the aspects of resisting tumor, resisting leukemia, resisting bacteria, resisting inflammation, resisting cancer, reducing blood sugar, inhibiting platelet aggregation, promoting long-term memory and the like, 5-methoxy-3-benzofuranone is also used as a key intermediate in the synthesis of 2, 3-dihydro-benzofuran compounds, the compounds can be used for treating or preventing melatonin related diseases, and 5-methoxy-3-benzofuranone is also used as an intermediate in the synthesis of 3-piperidine-4-acyl-1H-indole and 3- (1, 6-tetrahydropyridine) -1H-indole and 3- (1, 6-4-acyl) -indole derivatives such as the derivatives can be used for treating or preventing depression and the like in patent US 2005/004162. Therefore, it is of great importance to study the synthesis of 5-methoxy-3-benzofuranone.
In the prior art, under the action of alkali, the compound 2-bromo-1- (2-hydroxy-5-methoxyphenyl) ethanone is converted into the compound 5-methoxy-3-benzofuranone, the reaction yield is low, post-treatment is required to be performed with column chromatography purification, the purification time cost is high, and the method is not suitable for process amplification.
Disclosure of Invention
Aiming at the defects of the synthesis method of 5-methoxy-3-benzofuranone in the prior art, the invention aims to provide the synthesis method of 5-methoxy-3-benzofuranone, which has the advantages of simple post-treatment, ideal yield and suitability for process amplification.
In order to achieve the above purpose, the invention adopts the following technical scheme:
the synthesis process of 5-methoxy-3-benzofuranone includes converting 2-hydroxy-5-methoxy acetophenone as material into intermediate 2 (2-bromo-1- (2-hydroxy-5-methoxy phenyl) ethanone), and converting the intermediate 2 into target compound 3 (5-methoxy-3-benzofuranone) under the action of silica gel powder, and has the following synthesis process:
further, the synthesis method of the 5-methoxy-3-benzofuranone comprises the following steps:
(1) Adding the compound 1, namely 2-hydroxy-5-methoxyacetophenone, into an organic solvent I, adding copper bromide, heating to reflux under the protection of inert gas, and stirring for reaction for 10-36 hours. After the reaction is finished, the reaction liquid is subjected to post-treatment to obtain a compound 2;
(2) Adding silica gel powder into water, adding a compound 2, adding an organic solvent II, reacting for 2-5 hours at room temperature, and after the reaction is finished, carrying out post-treatment on the reaction solution to obtain a target compound 5-methoxy-3-benzofuranone.
Further, in the step (1), the organic solvent I is one or more of ethyl acetate, tetrahydrofuran, diethyl ether, methyl tertiary butyl ether, and methanol, and the 1, 4-dioxane.
Further, in step (1), the inert gas is selected from one or more of nitrogen or argon.
Further, in the step (1), the mass-volume ratio g/mL of the compound 1 to the organic solvent I is 1 (5-40).
Further, in the step (1), the molar ratio of the compound 1 to the copper bromide is 1 (1-5).
In the step (1), the post-treatment is to filter the reaction liquid, collect filtrate, spin-dry the filtrate to obtain crude product, and purify the crude product to obtain the compound 2.
Further, in step (1), the purification mode is selected from one or more of beating, column chromatography, recrystallization or distillation.
Further, in the step (2), the organic solvent II is acetonitrile or methanol or tetrahydrofuran or N, N-dimethylformamide or dimethyl sulfoxide.
Further, in the step (2), the mass ratio of the compound 2 to the silica gel powder is 1 (5-15).
In the step (2), methyl tertiary butyl ether is added into the reaction liquid for stirring, silica gel powder precipitation is waited for, then suction filtration is carried out, filtrate is collected, the filtrate is washed by water, saturated saline water is used for washing, the crude product is obtained after spin drying, and the crude product is purified to obtain the target compound 5-methoxy-3-benzofuranone.
Further, in the step (2), the purification mode is one or more of beating, column chromatography, recrystallization or distillation.
Compared with the prior art, the invention has the beneficial technical effects that:
The invention provides a synthesis method of 5-methoxy-3-benzofuranone, which takes 2-hydroxy-5-methoxy acetophenone as a raw material, firstly converts the 2-hydroxy-5-methoxy acetophenone into an intermediate 2 (2-bromo-1- (2-hydroxy-5-methoxy phenyl) ethanone), and converts the intermediate 2 into a target compound 3 (5-methoxy-3-benzofuranone) under the action of silica gel powder. In the key steps of the synthesis method, alkali is not used, but silica gel powder is used for replacing alkali, so that the post-reaction treatment and purification are simple, the reaction and time cost is greatly reduced, and the process amplification can be realized.
Drawings
FIG. 1 is a nuclear magnetic resonance hydrogen spectrum of 5-methoxy-3-benzofuranone in example 1 of the present invention.
Detailed Description
In order to make the technical solution and advantages of the embodiments of the present invention more clear, the technical solution of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings of the embodiments of the present invention. It will be apparent that the described embodiments are some, but not all, embodiments of the invention. All other embodiments, which can be made by a person skilled in the art without creative efforts, based on the described embodiments of the present invention fall within the protection scope of the present invention. Unless defined otherwise, technical or scientific terms used herein should be given the ordinary meaning as understood by one of ordinary skill in the art to which this invention belongs.
In the following examples, reagents and materials were used as commercially available unless otherwise specified.
The following examples synthesized 5-methoxy-3-benzofuranone starting from 2-hydroxy-5-methoxyacetophenone, which was first converted to intermediate 2 (2-bromo-1- (2-hydroxy-5-methoxyphenyl) ethanone), intermediate 2 was converted to the target compound 3 (5-methoxy-3-benzofuranone) by silica gel powder, which was synthesized as follows:
the technical scheme of the invention is further explained by the following examples.
Example 1
The compound 5-methoxy-3-benzofuranone was synthesized in this example as follows:
(1) Compound 1, namely 2-hydroxy-5-methoxyacetophenone (200.00 g,1.20mol,1.0 eq), was added to a mixed organic solvent of ethyl acetate (1.0L) and chloroform (1.0L), copper bromide (510.75 g,2.29mol,1.90 eq) was added, and the mixture was heated to reflux under nitrogen as an inert gas, followed by stirring for reaction for 12 hours. After the reaction was completed, the reaction solution was filtered, the filter cake was rinsed with ethyl acetate (1.0L), the filtrate was collected, the filtrate was dried by spin to give a crude product, which was slurried with petroleum ether, filtered, and the solid was collected and dried to give compound 2 (quality 281.20g, purity 96%, yield 92%).
(2) Silica gel powder (2000.00 g) was added to water (2.0L), compound 2 (200.00 g,816.09mmol,1.0 eq) was added, and acetonitrile (1.0L) was added and reacted at 25℃for 2 hours. After the completion of the reaction, methyl tert-butyl ether (5.0L) was added to the reaction mixture and stirred, the silica gel powder was allowed to precipitate, then suction filtration was performed, the filtrate was collected, washed with water, saturated brine, and dried by spin to give a crude product, which was slurried with petroleum ether, filtered, and dried to give the objective compound 5-methoxy-3-benzofuranone (quality 131.10g, purity 98%, yield 96%).
The nuclear magnetic hydrogen spectrum of the obtained compound 3 (5-methoxy-3-benzofuranone) is shown in figure 1, and the characterization data are as follows:
1H NMR(400MHz,cdcl3)δ7.29–7.17(m,1H),7.16–6.87(m,2H),4.64(s,2H),3.80(s,3H).
Examples 2 to 7
Examples 2 to 7 are the same as example 1 except that the amount of silica gel powder used in step (2), the organic solvent II, the reaction temperature, the reaction time, etc. are adjusted as shown in Table 1.
The effect of each reaction condition on the reaction yield in the synthesis of the objective compound 3 (5-methoxy-3-benzofuranone) was confirmed by examples 1 to 7, and the results are shown in Table 1.
TABLE 1 Synthesis conditions and results for examples
As can be seen from table 1:
In comparative examples 1 to 3, the reaction effect was already excellent when the mass ratio of the compound 2 to the silica gel powder was 1:10.
Comparative examples 1, 4-5, the reaction was carried out in the solvents acetonitrile, dichloromethane and acetone, with acetonitrile being the solvent more effective.
In comparative examples 1 and 6, the reaction effect was optimized at a reaction temperature of 25 ℃.
In comparative examples 1 and 7, the reaction time was 2 hours, and the reaction effect was optimized.
The foregoing is a preferred embodiment of the present invention, but the present invention should not be limited to the disclosure of this embodiment. So that equivalents and modifications will fall within the scope of the invention, all within the spirit and scope of the invention as disclosed.

Claims (10)

1.一种5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,以2-羟基-5-甲氧基苯乙酮为原料,先转化为中间体2(2-溴-1-(2-羟基-5-甲氧基苯基)乙酮),中间体2在硅胶粉作用下,转化为目标化合物3(5-甲氧基-3-苯并呋喃酮),合成路线如下:1. A method for synthesizing 5-methoxy-3-benzofuranone, characterized in that 2-hydroxy-5-methoxyacetophenone is used as a raw material, which is first converted into an intermediate 2 (2-bromo-1-(2-hydroxy-5-methoxyphenyl)ethanone), and the intermediate 2 is converted into a target compound 3 (5-methoxy-3-benzofuranone) under the action of silica gel powder. The synthetic route is as follows: 2.根据权利要求1所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,包括以下步骤:2. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 1, characterized in that it comprises the following steps: (1)将化合物1即2-羟基-5-甲氧基苯乙酮加入有机溶剂Ⅰ中,然后加入溴化铜,在惰性气体保护下,加热至回流,搅拌反应10-36小时,反应完成后,反应液经后处理,得到化合物2;(1) Compound 1, i.e., 2-hydroxy-5-methoxyacetophenone, is added to an organic solvent I, and then copper bromide is added. Under the protection of an inert gas, the mixture is heated to reflux and stirred for reaction for 10-36 hours. After the reaction is completed, the reaction solution is post-treated to obtain Compound 2; (2)将硅胶粉加入水中,加入化合物2,再加入有机溶剂Ⅱ,室温反应2-5小时,反应完成后,反应液经后处理,得到目标化合物3即5-甲氧基-3-苯并呋喃酮。(2) Add silica gel powder to water, add compound 2, and then add organic solvent II, and react at room temperature for 2-5 hours. After the reaction is completed, the reaction solution is post-treated to obtain the target compound 3, namely 5-methoxy-3-benzofuranone. 3.根据权利要求2所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(1)中,所述有机溶剂I为乙酸乙酯或氯仿或四氢呋喃或2-甲基四氢呋喃或乙醚或甲基叔丁基醚或甲醇或1,4-二氧六环中的一种或多种。3. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 2, characterized in that, in step (1), the organic solvent I is one or more of ethyl acetate, chloroform, tetrahydrofuran, 2-methyltetrahydrofuran, ether, methyl tert-butyl ether, methanol, or 1,4-dioxane. 4.根据权利要求2所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(1)中,所述惰性气体为氮气或氩气中的一种或多种。4. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 2, characterized in that in step (1), the inert gas is one or more of nitrogen or argon. 5.根据权利要求2所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(1)中:5. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 2, wherein in step (1): 所述化合物1与有机溶剂I的质量体积比g/mL为1:(5-40);The mass volume ratio of the compound 1 to the organic solvent I is 1:(5-40) g/mL; 所述化合物1与溴化铜的摩尔比为1:(1-5)。The molar ratio of the compound 1 to copper bromide is 1:(1-5). 6.根据权利要求2所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(1)中,所述后处理为将反应液过滤,收集滤液,将滤液旋干得到粗品,粗品经纯化,得到化合物2。6. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 2, characterized in that in step (1), the post-treatment is filtering the reaction solution, collecting the filtrate, and spin-drying the filtrate to obtain a crude product, which is purified to obtain compound 2. 7.根据权利要求6所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(1)中,所述纯化的方式为打浆、柱层析、重结晶或蒸馏中的一种或多种。7. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 6, characterized in that in step (1), the purification method is one or more of pulping, column chromatography, recrystallization or distillation. 8.根据权利要求2所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(2)中,所述有机溶剂Ⅱ为乙腈或甲醇或四氢呋喃或N,N-二甲基甲酰胺或二甲亚砜。8. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 2, characterized in that in step (2), the organic solvent II is acetonitrile or methanol or tetrahydrofuran or N,N-dimethylformamide or dimethyl sulfoxide. 9.根据权利要求2所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(2)中,所述化合物2与硅胶粉的质量比为1:(5-15)。9. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 2, characterized in that, in step (2), the mass ratio of the compound 2 to the silica gel powder is 1:(5-15). 10.根据权利要求2所述的5-甲氧基-3-苯并呋喃酮的合成方法,其特征在于,步骤(2)中,所述后处理为向反应液加入甲基叔丁基醚搅拌,等待硅胶粉沉淀,然后抽滤,收集滤液,将滤液用水洗,饱和食盐水洗涤,旋干得到粗品,粗品经纯化,得到目标化合物5-甲氧基-3-苯并呋喃酮。10. The method for synthesizing 5-methoxy-3-benzofuranone according to claim 2, characterized in that in step (2), the post-treatment is to add methyl tert-butyl ether to the reaction solution and stir, wait for the silica gel powder to precipitate, then filter, collect the filtrate, wash the filtrate with water, wash with saturated brine, and spin-dry to obtain a crude product, which is purified to obtain the target compound 5-methoxy-3-benzofuranone.
CN202411429506.4A 2024-10-14 2024-10-14 A kind of synthetic method of 5-methoxy-3-benzofuranone Pending CN119528857A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202411429506.4A CN119528857A (en) 2024-10-14 2024-10-14 A kind of synthetic method of 5-methoxy-3-benzofuranone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202411429506.4A CN119528857A (en) 2024-10-14 2024-10-14 A kind of synthetic method of 5-methoxy-3-benzofuranone

Publications (1)

Publication Number Publication Date
CN119528857A true CN119528857A (en) 2025-02-28

Family

ID=94700223

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202411429506.4A Pending CN119528857A (en) 2024-10-14 2024-10-14 A kind of synthetic method of 5-methoxy-3-benzofuranone

Country Status (1)

Country Link
CN (1) CN119528857A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070265332A1 (en) * 2006-05-15 2007-11-15 Min Ge Antidiabetic bicyclic compounds
CN103360352A (en) * 2013-08-05 2013-10-23 中国医学科学院药用植物研究所 Total synthesis method for 4-methoxy-2,6-dihydroxy-2-benzyl-3(2H)-benzofuranone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070265332A1 (en) * 2006-05-15 2007-11-15 Min Ge Antidiabetic bicyclic compounds
CN103360352A (en) * 2013-08-05 2013-10-23 中国医学科学院药用植物研究所 Total synthesis method for 4-methoxy-2,6-dihydroxy-2-benzyl-3(2H)-benzofuranone

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AILI SONG 等: "Total synthesis of a hydrated aurone derivative", JOURNAL OF CHINESE PHARMACEUTICAL SCIENCES, vol. 23, no. 10, 31 December 2014 (2014-12-31), pages 688 - 693 *
ZHI-HONG DONG 等: "Copper-Catalyzed Enantioselective 1, 2-Allylation of Azadienes with Allylboronates", ORG. LETT., vol. 26, 1 April 2024 (2024-04-01), pages 3235 - 3240 *
何敬文: "药物合成反应", vol. 1, 31 December 1995, 中国医药科技出版社, pages: 262 - 264 *

Similar Documents

Publication Publication Date Title
CN119528857A (en) A kind of synthetic method of 5-methoxy-3-benzofuranone
CN112047974B (en) Photodegradable bridged silane and preparation method thereof
CN114644612B (en) Preparation method of benzodiazepine nerve inhibitor intermediate compound
CN106083539B (en) A kind of synthetic method of list fluorine methoxyl group or the deuterated methoxy base class compound of single fluorine
CN113559926A (en) Asymmetric Aldol reaction catalyst and preparation method and application thereof
CN116554164B (en) A preparation method of Remigipam
CN115611860B (en) Method for synthesizing nilaparib
CN116813525B (en) Synthesis method of polyacetyl substituted oxindole compound
CN111253272B (en) Method for preparing benzamide compound
CN111333544B (en) Intermediate for synthesizing nilapanib and preparation method thereof
CN116102562B (en) A naphtho[2,1-b]indolo[2,3-d]cyclooctanolactone derivative and preparation method thereof
CN119684290A (en) Synthesis method of compound 3, 8-dibromophenanthroline and compound
CN115073485B (en) 3-Aryl-7,8-pyranocoumarin derivatives and preparation methods and applications thereof
CN119613320A (en) A method for synthesizing compound 3-iodo-1H-indole-2-carboxylic acid
CN118206444A (en) Synthesis method of 6-bromo-3-fluoro-2-methylbenzoic acid
CN115215779B (en) A kind of synthetic method based on spirocyclic ketone skeleton to synthesize different chiral spirocyclic compounds
CN105801328B (en) A kind of preparation method of coronene
CN118652255B (en) A process improvement method for pentoxifylline
CN118666838B (en) Asymmetric synthesis method of 1, 1-disubstituted-tetrahydro-beta-carboline derivative
CN116135869B (en) A method for refining troxerutin
CN119371386A (en) A method for synthesizing 6-bromo-3-benzofuranone
CN120965573A (en) Synthesis method of 2-bromo-5-fluoro-4-methoxypyridine
CN118652178A (en) A kind of synthetic method of methyl 4-bromo-2-fluoro-6-methylbenzoate
CN119191963A (en) A kind of synthetic method of 5-formyl-2,4-dimethylbenzoic acid
CN118993898A (en) 1, 7-Dihalogenated-1, 6-heptadiyne derivative and preparation method thereof, and polymer of 1, 7-dihalogenated-1, 6-heptadiyne derivative and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination